Bionor Pharma ASA
Records under this name other than patents Bionor Pharma ASA holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Bionor Pharma ASA
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,335,482 | Method of inducing an anti-HIV-1 immune response comprising administering a C5/TM-GP41 peptide dimer Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,501,499 | Peptides derived from viral proteins for use as immunogens and dosage reactants Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,925,691 | Drill bit Formerly held Lapsed on the fee record Ended Mar 27, 2026 · From the USPTO record | Lapsed on the fee record | Ended Mar 27, 2026 | From the USPTO record |
| US 10,449,245 | Method for reducing HIV-1 reservoir size using multivalent immunogen and reservoir purging agent Formerly held Lapsed on the fee record Ended Oct 22, 2023 · From the USPTO record | Lapsed on the fee record | Ended Oct 22, 2023 | From the USPTO record |
| US 10,143,737 | Method for the vaccination against HIV Formerly held Lapsed on the fee record Ended Dec 4, 2022 · From the USPTO record | Lapsed on the fee record | Ended Dec 4, 2022 | From the USPTO record |